Treatment results of CO2 laser vaporisation in a cohort of 35 patients with oral leukoplakia

Oral Diseases

Volumn 19, Issue 2, 2013, Pages 212-216

  Brouns, Erea ^a   Baart, Ja ^a   Karagozoglu, Kh ^a   Aartman, Iha ^b   Bloemena, E ^a   van der Waal, I ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Carbon dioxide laser; Malignant transformation; Oral leukoplakia; Potentially malignant oral disorders; Recurrence

Indexed keywords

ANALGESIC AGENT; CHLORHEXIDINE GLUCONATE; NONSTEROID ANTIINFLAMMATORY AGENT; CARBON DIOXIDE;

ADULT; AGED; ARTICLE; CARBON DIOXIDE LASER; CHEEK MUCOSA; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GINGIVA; HARD PALATE; HISTOPATHOLOGY; HUMAN; LASER SURGERY; LEUKOPLAKIA; LOWER LIP; MALE; MALIGNANT TRANSFORMATION; MOUTH; MOUTH PAIN; ORAL BIOPSY; ORAL SURGERY; OUTCOME ASSESSMENT; PHOTOGRAPHY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; TONGUE; EVALUATION STUDY; LEUKOPLAKIA, ORAL; LOW LEVEL LASER THERAPY; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARBON DIOXIDE; FEMALE; HUMANS; LASER THERAPY; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84878147166     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12007     Document Type: Article

References (23)

1. Bremmer JF, Brakenhoff RH, Broeckaert MA et al (2011). Prognostic value of DNA ploidy status in patients with oral leukoplakia. Oral Oncol 47: 956-960.
2. Brouns EREA, Bloemena E, Belien JA, Broeckaert MA, Aartman IH, Van der Waal I (2012). DNA ploidy measurement in oral leukoplakia: Different results between flow and image cytometry. Oral Oncol 48: 636-640.
3. Chandu A, Smith ACH (2005). The use of CO2 laser in the treatment of oral white patches: outcomes and factors affecting recurrence. Int J Oral Maxillofac Surg 34: 396-400.
4. Chiesa F, Tradati N, Sala L et al (1990). Follow-up of oral leukoplakia after carbon dioxide laser surgery. Arch Otolaryngol Head Neck Surg 116: 177-180.
5. Fisher SE, Frame JW (1984). The effects of the carbon dioxide surgical laser on oral tissues. Br J Oral Maxillofac Surg 22: 414-425.
6. Frame JW, Das Gupta AR, Dalton GA, Rhys Evans PH (1984). Use of the carbon dioxide laser in the management of premalignant lesions of the oral mucosa. J Laryngol Otol 98: 1251-1260.
7. Gooris PJ, Roodenburg JL, Vermey A, Nauta JM (1999). Carbon dioxide laser evaporation of leukoplakia of the lower lip: a retrospective evaluation. Oral Oncol 35: 490-495.
8. Hamadah O, Thomson PJ (2009). Factors affecting carbon dioxide laser treatment for oral precancer: a patient cohort study. Lasers Surg Med 41: 17-25.
9. Hamadah O, Goodson ML, Thomson PJ (2010). Clinicopathological behaviour of multiple oral dysplastic lesions compared with that of single lesions. Br J Oral Maxillofac Surg 48: 503-506.
10. Ishii J, Fujita K, Komori T (2003). Laser surgery as a treatment for oral leukoplakia. Oral Oncol 39: 759-769.
11. Ishii J, Fujita K, Munemoto S, Komori T (2004). Management of oral leukoplakia by laser surgery: relation between recurrence and malignant transformation and clinicopathological features. J Clin Laser Med Surg 22: 27-33.
12. Jerjes W, Upile T, Hamdoon Z et al (2012). CO2 laser of oral dysplasia: clinicopathological features of recurrence and malignant transformation. Lasers Med Sci 27: 169-179.
13. Lim B, Smith A, Chandu A (2010). Treatment of oral leukoplakia with carbon dioxide and potassium-titanyl-phosphate lasers: a comparison. J Oral Maxillofac Surg 68: 597-601.
14. Petti S (2003). Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol 39: 770-780.
15. Roodenburg JL, Panders AK, Vermey A (1991). Carbon dioxide laser surgery of oral leukoplakia. Oral Surg Oral Med Oral Pathol 71: 670-674.
16. Schoelch ML, Sekandari N, Regezi JA, Silverman S Jr (1999). Laser management of oral leukoplakias: a follow-up study of 70 patients. Laryngoscope 109: 949-953.
17. Thomson PJ, Wylie J (2002). Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management. Int J Oral Maxillofac Surg 31: 145-153.
18. Van der Hem PS, Nauta JM, Van der Wal JE, Roodenburg JL (2005). The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up. Oral Oncol 41: 31-37.
19. Van der Waal I (2009). Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45: 317-323.
20. Van der Waal I, Axell T (2002). Oral leukoplakia: a proposal for uniform reporting. Oral Oncol 38: 521-526.
21. Warnakulasuriya S, Johnson NW, Van der Waal I (2007). Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36: 575-580.
22. Yang SW, Wu CJ, Lee YS, Chen TA, Tsai CN (2010). Postoperative recurrence as an associated factor of malignant transformation of oral dysplastic leukoplakia. ORL J Otorhinolaryngol Relat Spec 72: 280-290.
23. Yang SW, Tsai CN, Lee YS, Chen TA (2011). Treatment outcome of dysplastic oral leukoplakia with carbon dioxide laser-emphasis on the factors affecting recurrence. J Oral Maxillofac Surg 69: e78-e87.